8801:TSEMitsui Fudosan Co., Ltd. Analysis
Data as of 2026-06-17 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
Mitsui Fudosan (8801.T) is trading at ¥1,516.5, just above its 20‑day SMA (¥1,513.7) but well below the 50‑day (¥1,615.3) and 200‑day (¥1,722.6) averages, signalling a short‑term bearish bias despite a bullish MACD histogram (+¥12.47) and a neutral RSI (45). The stock’s PE of 15x is dramatically lower than the industry average of 32.7x, and its price‑to‑book of 1.26 suggests it is undervalued relative to peers, while the dividend yield of 2.42% with a modest payout ratio (34.6%) appears sustainable. However, the balance sheet is heavily leveraged (Debt/Equity ≈ 137) and free cash flow is negative (‑¥170 bn), raising concerns about capital‑intensive growth and debt servicing. Volatility remains high at 43% over the past 30 days, yet beta is low (≈0.22), indicating limited sensitivity to broader market moves. Analyst consensus is strongly positive (11 analysts, “strong_buy”) with a median price target of ¥2,120, implying roughly 40% upside. The market sentiment is in “Extreme Greed” territory (Fear‑Greed Index 90.8), suggesting investors are currently optimistic despite the underlying risk factors.
Market Outlook
Short Term
< 1 yearKey Factors
- price hovering near immediate support (¥1,443.5)
- bullish MACD histogram suggesting limited upside bounce
- high volatility and decreasing volume
Medium Term
1–3 yearsKey Factors
- significant valuation gap versus industry PE
- sustainable dividend yield supporting total return
- analyst upside potential of ~40% toward median target
Long Term
> 3 yearsKey Factors
- stable Japanese real‑estate fundamentals and asset base
- low beta indicating resilience in varied market cycles
- ongoing dividend income and potential for debt reduction over time
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.